These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 34013582)
1. An analysis of the demographic history of the risk allele R4810K in RNF213 of moyamoya disease. Koganebuchi K; Sato K; Fujii K; Kumabe T; Haneji K; Toma T; Ishida H; Joh K; Soejima H; Mano S; Ogawa M; Oota H Ann Hum Genet; 2021 Sep; 85(5):166-177. PubMed ID: 34013582 [TBL] [Abstract][Full Text] [Related]
2. Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review. Liao X; Deng J; Dai W; Zhang T; Yan J Environ Health Prev Med; 2017 Nov; 22(1):75. PubMed ID: 29165161 [TBL] [Abstract][Full Text] [Related]
3. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease. Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847 [TBL] [Abstract][Full Text] [Related]
4. RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance. Zhang Q; Liu Y; Zhang D; Wang R; Zhang Y; Wang S; Yu L; Lu C; Liu F; Zhou J; Zhang X; Zhao J J Neurosurg; 2017 Apr; 126(4):1106-1113. PubMed ID: 27128593 [TBL] [Abstract][Full Text] [Related]
5. The Association of the RNF213 p.R4810K Polymorphism with Quasi-Moyamoya Disease and a Review of the Pertinent Literature. Zhang Q; Liu Y; Yu L; Duan R; Ma Y; Ge P; Zhang D; Zhang Y; Wang R; Wang S; Zhao Y; Cao Y; Liu X; Deng X; Zhao J; Zhang X World Neurosurg; 2017 Mar; 99():701-708.e1. PubMed ID: 28063898 [TBL] [Abstract][Full Text] [Related]
6. Systematic Validation of RNF213 Coding Variants in Japanese Patients With Moyamoya Disease. Moteki Y; Onda H; Kasuya H; Yoneyama T; Okada Y; Hirota K; Mukawa M; Nariai T; Mitani S; Akagawa H J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25964206 [TBL] [Abstract][Full Text] [Related]
7. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. Liu W; Morito D; Takashima S; Mineharu Y; Kobayashi H; Hitomi T; Hashikata H; Matsuura N; Yamazaki S; Toyoda A; Kikuta K; Takagi Y; Harada KH; Fujiyama A; Herzig R; Krischek B; Zou L; Kim JE; Kitakaze M; Miyamoto S; Nagata K; Hashimoto N; Koizumi A PLoS One; 2011; 6(7):e22542. PubMed ID: 21799892 [TBL] [Abstract][Full Text] [Related]
8. Rare and Low-Frequency Variants in RNF213 Confer Susceptibility to Moyamoya Syndrome Associated with Hyperthyroidism. Nomura S; Akagawa H; Yamaguchi K; Ishikawa T; Kawashima A; Kasuya H; Mukawa M; Nariai T; Maehara T; Okada Y; Kawamata T World Neurosurg; 2019 Jul; 127():e460-e466. PubMed ID: 30922903 [TBL] [Abstract][Full Text] [Related]
9. A new horizon of moyamoya disease and associated health risks explored through RNF213. Koizumi A; Kobayashi H; Hitomi T; Harada KH; Habu T; Youssefian S Environ Health Prev Med; 2016 Mar; 21(2):55-70. PubMed ID: 26662949 [TBL] [Abstract][Full Text] [Related]
10. Frequency of RNF213 p.R4810K, a susceptibility variant for moyamoya disease, and health characteristics of carriers in the Japanese population. Cao Y; Kobayashi H; Morimoto T; Kabata R; Harada KH; Koizumi A Environ Health Prev Med; 2016 Sep; 21(5):387-390. PubMed ID: 27365075 [TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population. Wu Z; Jiang H; Zhang L; Xu X; Zhang X; Kang Z; Song D; Zhang J; Guan M; Gu Y PLoS One; 2012; 7(10):e48179. PubMed ID: 23110205 [TBL] [Abstract][Full Text] [Related]
12. RNF213 p.R4810K Polymorphism and the Risk of Moyamoya Disease, Intracranial Major Artery Stenosis/Occlusion, and Quasi-Moyamoya Disease: A Meta-Analysis. Wang Y; Mambiya M; Li Q; Yang L; Jia H; Han Y; Liu W J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2259-2270. PubMed ID: 29752070 [TBL] [Abstract][Full Text] [Related]
13. Distribution of moyamoya disease susceptibility polymorphism p.R4810K in RNF213 in East and Southeast Asian populations. Liu W; Hitomi T; Kobayashi H; Harada KH; Koizumi A Neurol Med Chir (Tokyo); 2012; 52(5):299-303. PubMed ID: 22688066 [TBL] [Abstract][Full Text] [Related]
14. Ok T; Jung YH; Kim J; Park SK; Park G; Lee S; Lee KY J Am Heart Assoc; 2022 Aug; 11(15):e025676. PubMed ID: 35876407 [TBL] [Abstract][Full Text] [Related]
15. RNF213 rare variants in an ethnically diverse population with Moyamoya disease. Cecchi AC; Guo D; Ren Z; Flynn K; Santos-Cortez RL; Leal SM; Wang GT; Regalado ES; Steinberg GK; Shendure J; Bamshad MJ; ; Grotta JC; Nickerson DA; Pannu H; Milewicz DM Stroke; 2014 Nov; 45(11):3200-7. PubMed ID: 25278557 [TBL] [Abstract][Full Text] [Related]
16. Role of the Kim HJ; Choi EH; Chung JW; Kim JH; Kim YS; Seo WK; Kim GM; Bang OY J Am Heart Assoc; 2021 Jan; 10(1):e017660. PubMed ID: 33356381 [TBL] [Abstract][Full Text] [Related]
17. RNF213 Rare Variants in Slovakian and Czech Moyamoya Disease Patients. Kobayashi H; Brozman M; Kyselová K; Viszlayová D; Morimoto T; Roubec M; Školoudík D; Petrovičová A; Juskanič D; Strauss J; Halaj M; Kurray P; Hranai M; Harada KH; Inoue S; Yoshida Y; Habu T; Herzig R; Youssefian S; Koizumi A PLoS One; 2016; 11(10):e0164759. PubMed ID: 27736983 [TBL] [Abstract][Full Text] [Related]
18. Renovascular hypertension and Kim JY; Cho H Clin Nephrol; 2021 Aug; 96(2):105-111. PubMed ID: 33769276 [TBL] [Abstract][Full Text] [Related]
19. The Role of RNF213 4810G>A and 4950G>A Variants in Patients with Moyamoya Disease in Korea. Park YS; An HJ; Kim JO; Kim WS; Han IB; Kim OJ; Kim NK; Kim DS Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29160859 [TBL] [Abstract][Full Text] [Related]
20. Moyamoya Disease and Spectrums of RNF213 Vasculopathy. Bang OY; Chung JW; Kim DH; Won HH; Yeon JY; Ki CS; Shin HJ; Kim JS; Hong SC; Kim DK; Koizumi A Transl Stroke Res; 2020 Aug; 11(4):580-589. PubMed ID: 31650369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]